A multi-omics study of major depressive disorder
Part of Mental health clinical trials.
This study is collecting detailed information from people with depression and from healthy volunteers to better understand the biological factors involved. Participants will provide samples and complete assessments to help researchers identify new ways to diagnose and treat depression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 14 and 45 years old.
- You need to be able to understand the study and sign a consent form (if under 18, a parent or guardian must also consent).
- For the depression group: you must have a diagnosis of major depressive disorder and score at least 24 on a specific depression rating scale.
- For the healthy control group: you must have no current or past major psychiatric disorders and no significant family history of such disorders.
- You cannot be pregnant, breastfeeding, or have any severe or unstable medical condition.
- You cannot have other major psychiatric disorders like schizophrenia or bipolar disorder, or have had substance use disorder in the last year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how social factors and blood markers relate to psychiatric symptoms in people with brain diseases or mental disorders. It aims to find new ways to understand and diagnose these conditions.
This study tests an investigational medication (CYB003) for people with major depression whose current antidepressant isn't working well enough. It looks at whether this treatment can help improve depression symptoms.
This trial looks at brain and genetic markers to understand why depression returns. It is for people with major depression who are not currently taking medication.
This study looks at brain and behavior in teens aged 10–20 who are hospitalized for depression or bipolar disorder. It aims to better understand the condition and may help guide future treatments.
This study looks at adults with major depressive disorder who have responded to treatment, to find out what might predict a relapse. You will wear a wrist activity monitor and complete questionnaires.
This study is following and assessing people with major depression or bipolar disorder to better understand the condition and how the brain relates to symptoms. It may help researchers develop more targeted support by comparing brain and health information over time.
Hear when a new Major Depressive Disorder (MDD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.